Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy
Jie Liu, Shizhao Zhou, Yingying Wei, Jinglei Du, Fan Jia, Wenhui Dong, Yangyi Cao, Zhenyang Shi, Hongkai Mu, Lin Chen, Shiping Yu · 2025
Read Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy by Jie Liu, Shizhao Zhou, Yingying Wei, Jinglei Du, Fan Jia, Wenhui Dong, Yangyi Cao, Zhenyang Shi, Hongkai Mu, Lin Chen, Shiping Yu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753898.txt.
Description
Jie Liu and co-authors review tiny carriers built to beat drug resistance in liver cancer. Their 2025 review centers on sorafenib, a drug that often stops working as tumours adapt. Carriers made of nanoparticles can aim the drug better and use it more fully.
The review first maps the known ways tumours resist the drug. It then sorts carrier designs by their base material. Effects covered include reshaping the tissue around the tumour, fixing gene marks, and blocking over-active signals. The authors weigh the strong and weak points of each design. They close with the paths they expect the field to take next.
Catalog record
| CREATOR | Jie Liu, Shizhao Zhou, Yingying Wei, Jinglei Du, Fan Jia, Wenhui Dong, Yangyi Cao, Zhenyang Shi, Hongkai Mu, Lin Chen, Shiping Yu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |